Physician

Vipul A Savaliya, M.D

According to 2025 Medicare claims, Vipul Savaliya, M.D (NPI: 1528339660) practices hospitalist in the Fayetteville, NC market, with the plurality of this provider's patient population coming from Cumberland, NC. This provider's primary affiliated billing organization is ID CARE(R) - INFECTIOUS DISEASES SPECIALTY PRACTICE PA (NPI: 1033667761; TIN: 813746268) and primary practice location at 28304-3424.

Savaliya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 4,796 HCPCS/CPT codes, and received $222,557 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 177 prescription claims across 26 beneficiaries totaling $264,612 in drug costs, led by Odefsey (Emtricitab/Rilpiviri/Tenof Ala). 2016 DME data shows 33 claims. Open Payments data shows 17 records totaling $354. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $256,357 to $222,557. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,277,469 to $264,612. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,152	3,231	$256,357
2016	1,338	3,970	$294,688
2017	1,225	10,682	$744,188
2018	1,365	18,399	$909,190
2019	958	75,925	$827,826
2020	974	73,001	$800,788
2021	858	68,958	$476,764
2022	570	13,083	$321,680
2023	399	3,988	$203,298
2024	438	4,796	$222,557

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	134	490	$1,277,469
2016	162	599	$398,027
2017	180	802	$639,568
2018	188	1,122	$744,306
2019	135	729	$631,136
2020	114	563	$449,884
2021	44	286	$119,304
2022	47	404	$229,194
2023	27	247	$172,351
2024	26	177	$264,612

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	33	$56,084
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	11	12	$139
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	94	98	$117
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	396	2,214	$55
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	21	46	$46
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	110	2,296	$35

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	11	330	$46,173
Meropenem	Meropenem	17	126	$2,362
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	269	$116
Fluconazole	Fluconazole	11	369	$93

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$354	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vipul A. Savaliya, M.D?

Tedicare shows public-source Medicare data for Vipul A. Savaliya, M.D (NPI 1528339660), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vipul A. Savaliya, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vipul A. Savaliya, M.D?

Vipul A. Savaliya, M.D is linked to ID CARE(R) - INFECTIOUS DISEASES SPECIALTY PRACTICE PA (billing NPI 1033667761) in the available physician profile data.

Does Vipul A. Savaliya, M.D have Open Payments data?

Vipul A. Savaliya, M.D has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.